E20 - Re-inventing Precision Medicine with AI | Jolly Nanda, Founder and CEO, Altheia, Inc

Episode 20

0:00-37:21

In this episode, we sit down with Jolly Nanda, Founder and CEO of Altheia, Inc., to explore how artificial intelligence is transforming precision medicine from a reactive model into one that is predictive, personalized, and proactive. Jolly shares her entrepreneurial journey and the inspiration behind founding Altheia, highlighting the gaps she observed in traditional precision medicine approaches. While precision medicine has made meaningful progress, much of today’s healthcare system still reacts to disease after symptoms appear. Jolly explains how AI-driven insights are changing that paradigm—unlocking deeper understanding from complex patient data, accelerating diagnostics, and enabling earlier, more targeted interventions. At the core of the conversation is the convergence of AI, clinical data, genomics, and digital health. By integrating multi-omics datasets with real-world clinical information, machine learning models can identify subtle patterns and correlations that would otherwise remain hidden. These insights allow for improved disease prediction, earlier detection, and more individualized therapeutic strategies tailored to each patient’s biological profile. We also discuss the practical realities of building and scaling AI solutions in healthcare. From regulatory and interoperability challenges to adoption within clinical and commercial environments, Jolly outlines the importance of balancing innovation with trust, transparency, and governance.

Publisher

Life Science Insights 360 Podcasts

Link

podcasters.spotify.com/pod/show/life-science-insights360/episodes/E20---Re-inventing-Precision-Medicine-with-AI--Jolly-Nanda--Founder-and-CEO--Altheia--Inc-e3fcagf

Published

February 9, 2026

Duration

37 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

Life Science Insights360

LS

Life Science Insights 360 Podcasts

@lifescienceinsights360podcas

#inventingprecisionmedicine #jollynanda #founder #lifesciences

The Nile